Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

152 results about "Corynebacterium crenatum" patented technology

Corynebacterium crenatum is a fast-growing, aerobic, gram-positive, non-sporulating coryneform bacterium. It is often used to produce large quantities of some long-chain amino acids such as leucine, isoleucine and arginine for industrial applications [25-27].

Metabolic transformation method for efficiently improving production capacity of corynebacterium crenatum SYPA5-5 L-arginine

InactiveCN104059863ABacteriaMutant preparationTranscriptional analysisBacterial strain
The invention provides a metabolic transformation strategy for efficiently improving production capacity of corynebacterium crenatum SYPA5-5 L-arginine, and belongs to the biological technical field. Histidine at a site 268 in N-acetyl glutamatekinase, NAGK, argB of SYPA-5 is mutated into asparaginate, so that feedback inhibition effect of the L-arginine on NAGK can be effectively relived; a mutation site is precisely introduced to a corresponding position of SYPA5-5 genome, so that yield of the obtained feedback inhibition-preventing bacterial strain (H-7)L-arginine is lowered, and metabolic intermediate (L-ornithine and L-citrulline) is largely accumulated. Transcriptional analysis is carried out on an arg gene cluster of h-7 to find that arg GH transcriptional level is lowered. Arg GH reinforced expression is carried out in H-7, and production capacity of the obtained recombinant bacterial strain H-7-GH, L-arginine is improved by 99.0% in comparison with SYPA5-5. Preliminary optimization is carried out on a fermentation culture medium of H-7-GH, so that yield of the L-arginine is 45.1g/L, which is improved by 49.8% in comparison with that before optimization, and improved by 1.13 times in comparison with SYPA5-5. Feedback inhibition of the L-arginine on NAGK is relieved, and metabolic transformation strategy of the arg GH gene is expressed in a strengthened manner at the same time, so that production capacity of the L-arginine of the SYPA 5-5 is effectively improved.
Owner:JIANGNAN UNIV

One-step method for synthesizing gamma-aminobutyric acid by using recombinant corynebacterium crenatum and with glucose as substrate

The invention belongs to the fields of genetic engineering and enzyme engineering, and relates to a one-step method for synthesizing gamma-aminobutyric acid by using recombinant corynebacterium crenatum (C.crenatum) and with glucose as a substrate. According to the method, a genetic engineering method is adopted, C.crenatum SYPA5-5 gene argB is knocked out, such that a safe strain C.crenatum E01 which can accumulate glutamic acid is obtained; a glutamic acid decarboxylase gene is cloned from L.Plantarum GB01-21 and is expressed in the C.crenatum E01, such that recombinant C.crenatum E01 / pGAD used for directly synthesizing gamma-aminobutyric acid with glucose as a substrate is obtained. A recombinant strain fermentation broth gamma-aminobutyric acid accumulation reaches 13.98g / L. According to the invention, glutamic acid and gamma-aminobutyric acid metabolic pathways are successfully integrated, such that one-step production from glucose to gamma-aminobutyric acid is realized. Therefore, preparation method is simplified, cost is reduced, safety is improved, and novel idea is provided for high-efficiency and low-cost amino acid preparation.
Owner:南宁汉和生物科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products